Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can exercise protect diabetic joints? new study investigates

NCT ID NCT04893135

First seen May 30, 2026 · Last updated Jun 19, 2026 · Updated 3 times

Summary

This study looked at how quickly bringing high blood sugar under control, combined with moderate treadmill walking, affects certain proteins linked to bone health in people with type 2 diabetes. The goal was to understand why some patients develop a rare but serious joint condition called Charcot neuroarthropathy. Sixty adults with poorly controlled diabetes participated, and researchers measured changes in the RANKL/OPG system, which regulates bone turnover.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE-2 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre Hospitalier Sud Francilien

    Corbeil-Essonnes, France, 91100, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

treadmill walking

What this could lead to

If successful, this could help explain why some diabetes patients develop joint problems, potentially pointing to ways to prevent it.

What could go wrong

This is a small, completed observational study with only 60 participants. It measures biological markers, not direct health outcomes, so results may not lead to clear treatments.

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.